In this issue of Thoracic Surgery Clinics, guest editors Drs. Brendon M. Stiles and Tamar B. Nobel bring their considerable expertise to the topic of Advances in Systemic Therapy for Lung Cancer. Recent advances in systemic therapies, marked by ongoing clinical trials and new drug approvals, have revolutionized the treatment landscape, offering new hope for patients with lung cancer. This issue features articles by top experts who explore various topics including novel neoadjuvant and adjuvant clinical trials that could redefine standard care protocols.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. viii 7. Foreword - p. ix 8. Neoadjuvant Immunotherapy - p. 1 9. Neoadjuvant Chemoimmunotherapy - p. 9 10. Neoadjuvant Tyrosine Kinase Inhibitors - p. 25 11. Surgical Challenges After Neoadjuvant Therapy - p. 41 12. Adjuvant Immunotherapy in Lung Cancer: Foundational Successes and Future Directions - p. 49 13. The Evolving Role of Adjuvant TKI in Lung Cancer: From Historical Trials to Future Strategies National Cancer Center Hospital East, Japan - p. 59 14. Neoadjuvant, Adjuvant, or Both? Optimizing Perioperative Systemic Therapy in Lung Cancer - p. 71 15. Adding Immunotherapy and Targeted Therapy to Chemoradiotherapy for Non-small Cell Lung Cancer - p. 83 16. Update on Neoadjuvant and Adjuvant Trials - p. 91 17. Advances in Systemic Therapy for Lung Cancer: Update on Biomarkers and Novel Drugs for Patients with Stage IV Non-Small Cell Lung Cancer (NSCLC) - p. 99 18. Role of Surgery for Patients with Metastatic Non-small Cell Lung Cancer - p. 115
In this issue of Thoracic Surgery Clinics, guest editors Drs. Brendon M. Stiles and Tamar B. Nobel bring their considerable expertise to the topic of Advances in Systemic Therapy for Lung Cancer. Recent advances in systemic therapies, marked by ongoing clinical trials and new drug approvals, have revolutionized the treatment landscape, offering new hope for patients with lung cancer. This issue features articles by top experts who explore various topics including novel neoadjuvant and adjuvant clinical trials that could redefine standard care protocols.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. viii 7. Foreword - p. ix 8. Neoadjuvant Immunotherapy - p. 1 9. Neoadjuvant Chemoimmunotherapy - p. 9 10. Neoadjuvant Tyrosine Kinase Inhibitors - p. 25 11. Surgical Challenges After Neoadjuvant Therapy - p. 41 12. Adjuvant Immunotherapy in Lung Cancer: Foundational Successes and Future Directions - p. 49 13. The Evolving Role of Adjuvant TKI in Lung Cancer: From Historical Trials to Future Strategies National Cancer Center Hospital East, Japan - p. 59 14. Neoadjuvant, Adjuvant, or Both? Optimizing Perioperative Systemic Therapy in Lung Cancer - p. 71 15. Adding Immunotherapy and Targeted Therapy to Chemoradiotherapy for Non-small Cell Lung Cancer - p. 83 16. Update on Neoadjuvant and Adjuvant Trials - p. 91 17. Advances in Systemic Therapy for Lung Cancer: Update on Biomarkers and Novel Drugs for Patients with Stage IV Non-Small Cell Lung Cancer (NSCLC) - p. 99 18. Role of Surgery for Patients with Metastatic Non-small Cell Lung Cancer - p. 115
